Connect
MJA
MJA

Pharmaceutical preparations

Letters

Rethinking psychotropics in nursing homes

Juanita L Westbury and Gregory M Peterson

Med J Aust 2013; 199 (2): 98

Letters

Rethinking psychotropics in nursing homes

Ludomyr J Mykyta

Med J Aust 2013; 199 (2): 98-99

Letters

Rethinking psychotropics in nursing homes

Sarah N Hilmer and Danijela Gnjidic

Med J Aust 2013; 199 (2): 99

Reflections

The case for CBT over antidepressants

Kay A Wilhelm

Med J Aust 2013; 198 (9): 507

Perspectives

Is there really misuse and abuse of dabigatran?

John W Eikelboom and Graeme J Hankey

Med J Aust 2013; 198 (7): 358-359 Free

Clinical focus

Mass or molar? Recommendations for reporting concentrations of therapeutic drugs

Graham R D Jones, Stewart Bryant, Robert Fullinfaw, Ken Ilett, John O Miners, Raymond G Morris and Matthew P Doogue

Med J Aust 2013; 198 (7): 368-369 Free

Letters

The pricing of statins and implications for Pharmaceutical Benefits Scheme expenditure

Philip M Clarke

Med J Aust 2013; 198 (5): 260

Research

Prescribing trends before and after implementation of an antimicrobial stewardship program

Kelly A Cairns, Adam W J Jenney, Iain J Abbott, Matthew J Skinner, Joseph S Doyle, Michael Dooley and Allen C Cheng

Med J Aust 2013; 198 (5): 262-266 Free

Perspectives

Rethinking psychotropics in nursing homes

Sarah N Hilmer and Danijela Gnjidic

Med J Aust 2013; 198 (2): 77

Perspectives

Real-time monitoring of Schedule 8 medicines in Australia: evaluation is essential

Fiona L Shand, Gabrielle Campbell, Wayne Hall, Nicholas Lintzeris, Milton Cohen and Louisa Degenhardt

Med J Aust 2013; 198 (2): 80-81

Letters

Importance of ambulatory blood pressure in hypertension management

Patrick Coleman

Med J Aust 2013; 198 (1): 25-26

Letters

Importance of ambulatory blood pressure in hypertension management

Geoffrey A Head, Barry P McGrath, Mark R Nelson and Michael Stowasser

Med J Aust 2013; 198 (1): 26

Christmas crackers

The hazards of brussels sprouts consumption at Christmas

Stephen J Pettit, Alan G Japp and Roy S Gardner

Med J Aust 2012; 197 (11): 661-662

Perspectives

Can we feel it in our waters? Antimicrobials in aquaculture

Mary D Barton and Olasumbo L Ndi

Med J Aust 2012; 197 (9): 487-488

Editorials

A life-cycle approach to monitoring benefits and harms of medicines

Emily Banks and Sallie-Anne Pearson

Med J Aust 2012; 197 (6): 313-314

Letters

Pharmacoepidemiology of testosterone prescribing in Australia, 1992–2010

Stephen P Fitzgerald

Med J Aust 2012; 197 (6): 329-330

Letters

Pharmacoepidemiology of testosterone prescribing in Australia, 1992–2010

Peter M Herriot

Med J Aust 2012; 197 (6): 330

Letters

Simulation in clinical teaching and learning

Susan A Welch, Julie L Gawthorne and Melinda J Berry

Med J Aust 2012; 197 (6): 331-332

Letters

The Jarisch–Herxheimer reaction in a patient with leptospirosis: a foreseeable problem in managing spirochaete infections

Ryan Markham, Andrew Slack and John Gerrard

Med J Aust 2012; 197 (5): 276-277

Editorials

Drug treatment for melanoma: progress, but who pays?

Richard F Kefford

Med J Aust 2012; 197 (4): 198-199 Free

Perspectives

Drug policy at the margins: the case of growth hormone replacement for adults with severe growth hormone deficiency

Wendy L Lipworth, Ken Ho, Ian H Kerridge and Richard O Day

Med J Aust 2012; 197 (4): 204-205 Free

Letters

A screening program to detect aminoglycoside- induced ototoxicity

Maryam Teimoori, Gina Mistry, Carmela Corallo and Allen C Cheng

Med J Aust 2012; 197 (4): 216-217

Letters

Is the non-medical use of prescription stimulants a problem in Australia?

Jayne C Lucke and Wayne D Hall

Med J Aust 2012; 197 (3): 145

Editorials

Gentamicin and ototoxicity: why this drug is still in use

John D Turnidge and John A Waterston

Med J Aust 2012; 196 (11): 665-666

Perspectives

Disease mongering and low testosterone in men: the tale of two regulatory failures

Agnes I Vitry and Barbara Mintzes

Med J Aust 2012; 196 (10): 619-621